ADVANCED MALIGNANT TUMOUR
Clinical trials for ADVANCED MALIGNANT TUMOUR explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANT TUMOUR trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANT TUMOUR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug called HRS-7058 combined with other cancer drugs in people with advanced solid tumors that cannot be removed by surgery or have spread. The goal is to find safe doses and see if the combination shrinks tumors. About 300 adults aged 18 to 75 with good p…
Matched conditions: ADVANCED MALIGNANT TUMOUR
Phase: PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 00:46 UTC
-
New targeted drug HRS-7058 enters human trials for Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called HRS-7058 in people with advanced solid tumors that have a specific KRAS G12C mutation. The main goals are to find a safe dose and check how well the drug works. About 233 adults aged 18 to 75 with advanced cancer will take part.
Matched conditions: ADVANCED MALIGNANT TUMOUR
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 00:28 UTC